EMVision Medical Devices Ltd announced a private placement of 7,454,231 common shares at a price of AUD 2.05 per share for gross proceeds of AUD 15,281,173.55 on February 28, 2024. The transaction included participation from new investor Keysight Technologies, Inc. to acquire an 8.73% shareholding in the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.965 AUD | +2.34% |
|
-10.27% | +15.93% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
136.4 USD | +1.13% | -0.81% | 23.55B | ||
1.965 AUD | +2.34% | -10.27% | 109M | ||
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+15.93% | 109M | |
+0.59% | 207B | |
+3.92% | 181B | |
+30.07% | 155B | |
+32.42% | 112B | |
+1.98% | 64.42B | |
+19.65% | 54.38B | |
-1.86% | 47.43B | |
-9.53% | 37.17B | |
-1.28% | 34.81B |
- Stock Market
- Equities
- EMV Stock
- News EMVision Medical Devices Ltd
- EMVision Medical Devices Ltd announced that it expects to receive AUD 15.281174 million in funding from Keysight Technologies, Inc.